Cullinan Therapeutics, Inc. (NASDAQ: CGEM)

$13.45 +0.40 (+3.07%)
As of May 01, 2026 03:59 PM
Sector: Healthcare Industry: Biotechnology CIK: 0001789972
P/E -0.38
Add ratio to table...

About

Research and Development Expenses Axis Breakdown of Revenue (2025)

Statement of Income Location, Balance Breakdown of Revenue (2025)

Peer comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 VRTX Vertex Pharmaceuticals Inc / Ma 109.90 Bn 27.78 9.16 -
2 REGN Regeneron Pharmaceuticals, Inc. 76.53 Bn 16.96 5.34 1.99 Bn
3 ALNY Alnylam Pharmaceuticals, Inc. 39.60 Bn 143.93 12.57 -
4 RVMD Revolution Medicines, Inc. 27.52 Bn -24.37 33,158.07 -
5 ZLAB Zai Lab Ltd 24.25 Bn -138.37 100.02 0.20 Bn
6 MESO Mesoblast Ltd 22.87 Bn -179.20 1,330.04 0.12 Bn
7 RPRX Royalty Pharma plc 21.29 Bn 27.68 8.95 8.95 Bn
8 ROIV Roivant Sciences Ltd. 19.34 Bn -31.53 3,368.96 -